Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M223,732Revenue (TTM) $M50,992Net Margin (%)14.9Altman Z-Score2.6
Enterprise Value $M243,964EPS (TTM) $1.2Operating Margin %25.0Piotroski F-Score6
P/E(ttm)30.2Beneish M-Score-2.6Pre-tax Margin (%)18.5Higher ROA y-yN
Price/Book3.610-y EBITDA Growth Rate %2.6Quick Ratio1.2Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %0.6Current Ratio1.4Lower Leverage y-yY
Price/Free Cash Flow16.5y-y EBITDA Growth Rate %-14.6ROA % (ttm)4.6Higher Current Ratio y-yN
Dividend Yield %3.1PEG50.2ROE % (ttm)11.6Less Shares Outstanding y-yY
Payout Ratio %93.0Shares Outstanding M6,065ROIC % (ttm)12.1Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactup Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEMario Gabelli 2015-12-31 Reduce$31.33 - $35.45
($33.17)
$ 36.8911%Reduce -3.16%706,956
PFERuane Cunniff 2015-12-31 Add$31.33 - $35.45
($33.17)
$ 36.8911%Add 31.39%14,850
PFEDavid Dreman 2015-12-31 Sold Out -0.02%$31.33 - $35.45
($33.17)
$ 36.8911%Sold Out0
PFEBarrow, Hanley, Mewhinney & Strauss 2015-12-31 Reduce-0.02%$31.33 - $35.45
($33.17)
$ 36.8911%Reduce -0.76%53,862,996
PFEKen Fisher 2015-12-31 Add0.03%$31.33 - $35.45
($33.18)
$ 36.8911%Add 1.28%32,334,417
PFEJohn Keeley 2015-12-31 Reduce-0.04%$31.33 - $35.45
($33.17)
$ 36.8911%Reduce -38.66%77,749
PFEPrem Watsa 2015-12-31 Reduce-0.07%$31.33 - $35.45
($33.17)
$ 36.8911%Reduce -10.64%210,000
PFECharles Brandes 2015-12-31 Reduce-0.1%$31.33 - $35.45
($33.17)
$ 36.8911%Reduce -3.82%5,639,537
PFEJohn Paulson 2015-12-31 Buy 0.13%$31.33 - $35.45
($33.17)
$ 36.8911%New holding632,700
PFEVanguard Health Care Fund 2015-12-31 Reduce-0.25%$31.33 - $35.45
($33.17)
$ 36.8911%Reduce -29.31%8,872,226
PFET Rowe Price Equity Income Fund 2015-12-31 Add0.28%$31.33 - $35.45
($33.18)
$ 36.8911%Add 15.28%14,525,000
PFEJoel Greenblatt 2015-12-31 Sold Out -0.32%$31.33 - $35.45
($33.17)
$ 36.8911%Sold Out0
PFEFirst Eagle Investment 2015-12-31 Reduce-0.47%$31.33 - $35.45
($33.17)
$ 36.8911%Reduce -97.77%135,661
PFEKahn Brothers 2015-12-31 Reduce-0.59%$31.33 - $35.45
($33.17)
$ 36.8911%Reduce -6.05%1,569,873
PFENWQ Managers 2015-12-31 Reduce-1.16%$31.33 - $35.45
($33.17)
$ 36.8911%Reduce -54.84%1,967,718
PFEDodge & Cox 2015-12-31 Reduce-1.36%$31.33 - $35.45
($33.17)
$ 36.8911%Reduce -95.04%2,243,178
PFEDavid Tepper 2015-12-31 Buy 1.55%$31.33 - $35.45
($33.17)
$ 36.8911%New holding2,412,250
PFELeon Cooperman 2015-12-31 Reduce-2.24%$31.33 - $35.45
($33.17)
$ 36.8911%Reduce -73.18%1,295,600
PFERuane Cunniff 2015-09-30 Add$30.82 - $36.15
($33.8)
$ 36.899%Add 3.05%11,302
PFEDodge & Cox 2015-09-30 Add$30.82 - $36.15
($33.8)
$ 36.899%Add 0.07%45,266,436
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DAMELIO FRANK AExecutive Vice President 2016-05-26Sell100,000$34.496.96view
CANGIALOSI LORETTA VSr. Vice President, Controller 2016-05-24Sell86,000$33.978.6view
OLSON LAURIE JExecutive Vice President 2016-05-11Sell4,700$33.510.12view
YOUNG JOHN DGroup President 2016-05-10Sell41,700$33.5310.02view
DAMELIO FRANK AExecutive Vice President 2016-05-10Sell192,000$33.669.6view
READ IAN CChairman & CEO 2016-05-09Sell275,000$33.89.14view
SUSMAN SALLYExecutive Vice President 2016-05-09Sell67,884$33.719.43view
HILL CHARLES HExecutive Vice President 2016-05-09Sell29,600$33.849.01view
MADDALUNA ANTHONY JExecutive Vice President 2016-05-09Sell8,950$33.759.3view
SUSMAN SALLYExecutive Vice President 2016-05-05Sell76,116$33.759.3view

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    Technology Earnings Helping Market to Gain Jul 20 2016 
    US Market Indexes Achieve New Highs Jul 14 2016 
    Investing in Big Pharma: Pointers on Pfizer Jul 14 2016 
    John Burbank's Best Investments Jul 14 2016 
    Investors Cautious in Trading as Stocks End Day Lower Jun 22 2016 
    U.S. Market Indexes Gain as Investors Await UK Vote Jun 21 2016 
    Pfizer, Merck, Other Big Pharmas Likely to Acquire Marijuana-Based Drug Companies Jun 13 2016 
    U.S. Stocks Trade Flat at Start of Week May 09 2016 
    UnitedHealth’s Obamacare Changes to Affect Healthcare Sector Apr 27 2016 
    Does Biotech’s Recent Bounce Have Legs? Apr 22 2016 

    More From Other Websites
    Tech Lights the Way on Strong Earnings Jul 29 2016
    Pfizer (PFE) Likely to Beat Earnings in Q2 Again Jul 29 2016
    Big earnings ahead Jul 29 2016
    Pfizer Exits Brazil: Teva Is Suitor (PFE, TEVA) Jul 29 2016
    Make Drugmakers Pay: England’s Strategy for Cancer Medicines Jul 28 2016
    Pfizer Announces Positive Top-Line Results from Pivotal Phase 3 Maintenance Trial of Oral XELJANZ®... Jul 28 2016
    4:11 pm Pfizer announces top-line results from Oral Clinical Trials for tofAcitinib in ulceratiVE... Jul 28 2016
    Pfizer Announces Positive Top-Line Results from Pivotal Phase 3 Maintenance Trial of Oral XELJANZ®... Jul 28 2016
    Pfizer (PFE) Stock Down, Partners with Western Oncolytics on Cancer Technology Jul 28 2016
    Jim Cramer: Second-Quarter Earnings Have Been Mixed Jul 28 2016
    [$$] Bristol-Myers Raises Yearly Outlook Jul 28 2016
    Pfizer And Western Oncolytics Reach Immuno-Oncology Research Collaboration Jul 28 2016
    Pfizer and Western Oncolytics Announce Immuno-Oncology Research Collaboration to Investigate Novel... Jul 28 2016
    Pfizer and Western Oncolytics Announce Immuno-Oncology Research Collaboration to Investigate Novel... Jul 28 2016
    AstraZeneca helped by new drugs as cholesterol pill fades Jul 28 2016
    AstraZeneca a takeover target again? CEO not commenting Jul 28 2016
    [$$] Specialty-Pharma Startup Nevakar Raises $55M Jul 27 2016
    Options Insight: Is Pfizer the Right Prescription? Jul 27 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)